Increased body mass index as a risk factor in localized prostate cancer treated by radical prostatectomy

Urologic Oncology: Seminars and Original Investigations - Tập 34 - Trang 254.e1-254.e6 - 2016
Maximilien C. Goris Gbenou1,2,3, Alexandre Peltier2,3, Claude C. Schulman3,4, Roland van Velthoven2,3
1Department of Urology, Valence Hospital, Valence, France
2Department of Urology, University Hospital—Jules Bordet Institute, Brussels, Belgium
3Faculty of Medicine, Université Libre de Bruxelles, Brussels, Belgium
4Department of Urology, Edith Cavell Clinic, Brussels, Belgium

Tài liệu tham khảo

Golabek, 2014, Obesity and prostate cancer incidence and mortality: a systematic review of prospective cohort studies, Urol Int, 92, 7, 10.1159/000351325 Zhang, 2015, Impact of obesity upon prostate cancer-associated mortality: a meta-analysis of 17 cohort studies, Oncol Lett, 9, 1307, 10.3892/ol.2014.2841 Calle, 2003, Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults, N Engl J Med, 348, 1625, 10.1056/NEJMoa021423 Discacciati, 2012, Body mass index and incidence of localized and advanced prostate cancer—a dose-response meta-analysis of prospective studies, Ann Oncol, 23, 1665, 10.1093/annonc/mdr603 Bassett, 2012, Weight change and prostate cancer incidence and mortality, Int J Cancer, 131, 1711, 10.1002/ijc.27414 Freedland, 2009, Obese men have higher-grade and larger tumors: an analysis of the duke prostate center database, Prostate Cancer Prostatic Dis, 12, 259, 10.1038/pcan.2009.11 Gross, 2009, Expression of androgen and estrogen related proteins in normal weight and obese prostate cancer patients, Prostate, 69, 520, 10.1002/pros.20901 Capitanio, 2012, Influence of obesity on tumour volume in patients with prostate cancer, BJU Int, 109, 678, 10.1111/j.1464-410X.2011.10453.x Balssa, 2015, Impact of obesity on pathologic outcomes and biochemical reccurence after radical prostatectomy, Prog Urol, 25, 420, 10.1016/j.purol.2015.03.004 de Cobelli, 2015, Body mass index was associated with upstaging and upgrading in patients with low-risk prostate cancer who met the inclusion criteria for active surveillance, Urol Oncol, 33, e1, 10.1016/j.urolonc.2015.02.004 Xie, 2007, Obesity and benign prostatic enlargement: a large observational study in China, Urology, 69, 680, 10.1016/j.urology.2006.12.030 Hong, 2012, Prostate weight is the preferred measure of prostate size in radical prostatectomy cohorts, BJU Int, 109, 57, 10.1111/j.1464-410X.2012.11049.x Kopp, 2011, Obesity and prostate enlargement in men with localized prostate cancer, BJU Int, 108, 1750, 10.1111/j.1464-410X.2011.10227.x Goris Gbenou, 2012, Localising prostate cancer: comparison of endorectal magnetic resonance (MR) imaging and 3D-MR spectroscopic imaging with transrectal ultrasound-guided biopsy, Urol Int, 88, 12, 10.1159/000331909 Ploussard, 2012, The risk of upstaged disease increases with body mass index in low-risk prostate cancer patients eligible for active surveillance, Eur Urol, 61, 356, 10.1016/j.eururo.2011.07.041 Mitchell, 2011, Does body mass index dilute the predictive property of prostate-specific antigen for tumor volume at radical prostatectomy?, Urology, 78, 868, 10.1016/j.urology.2011.05.060 Hsing, 2007, MSR1 variants and the risks of prostate cancer and benign prostatic hyperplasia: a population-based study in China, Carcinogenesis, 28, 2530, 10.1093/carcin/bgm196 Amling, 2004, The association between obesity and the progression of prostate and renal cell carcinoma, Urol Oncol, 22, 478, 10.1016/j.urolonc.2004.10.004 Freedland, 2004, Impact of obesity on biochemical control after radical prostatectomy for clinically localized prostate cancer: a report by the Shared Equal Access Regional Cancer Hospital database study group, J Clin Oncol, 22, 446, 10.1200/JCO.2004.04.181 Grubb, 2009, Serum prostate-specific antigen hemodilution among obese men undergoing screening in the prostate, lung, colorectal, and ovarian cancer screening trial, Cancer Epidemiol Biomarkers Prev, 18, 748, 10.1158/1055-9965.EPI-08-0938 Bassett, 2005, Impact of obesity on prostate cancer recurrence after radical prostatectomy: data from CaPSURE, Urology, 66, 1060, 10.1016/j.urology.2005.05.040 Strom, 2005, Obesity, weight gain, and risk of biochemical failure among prostate cancer patients following prostatectomy, Clin Cancer Res, 11, 6889, 10.1158/1078-0432.CCR-04-1977 Amling, 2004, Pathologic variables and recurrence rates as related to obesity and race in men with prostate cancer undergoing radical prostatectomy, J Clin Oncol, 22, 439, 10.1200/JCO.2004.03.132 Ly, 2010, Association of body mass index with prostate cancer biochemical failure, J Urol, 183, 2193, 10.1016/j.juro.2010.02.010 Briganti, 2009, Obesity does not increase the risk of lymph node metastases in patients with clinically localized prostate cancer undergoing radical prostatectomy and extended pelvic lymph node dissection, Int J Urol, 16, 676, 10.1111/j.1442-2042.2009.02330.x Brand, 2011, Testosterone, sex hormone-binding globulin and the metabolic syndrome: a systematic review and meta-analysis of observational studies, Int J Epidemiol, 40, 189, 10.1093/ije/dyq158 Tewari, 2012, Diet, obesity, and prostate health: are we missing the link, J Androl, 33, 763, 10.2164/jandrol.111.015578